| No images? Click here  Friday 02.2621 | Issue 99 WHO / Blink Media - Mustafa Saeed Coronavirus disease (COVID-19) updates Virtual press briefings with simultaneous translation in all UN languages with the participation of the WHO Director-General are planned for this week. Media advisories with Zoom links/dial-in details will be emailed in advance.  Monday, 1 March Yemen conference 2021: High Level Pledging Event for the Humanitarian Crises in Yemen WHO's Director-General will join Monday's virtual high-level pledging event for the humanitarian crisis in Yemen convened by the United Nations and co-hosted by the Governments of Sweden and Switzerland. The main purpose is for participating Member States and other donors to announce pledges to address the dire needs in the country. More on the event. Yemen remains the world’s largest humanitarian crisis and its largest humanitarian response with more than 20 million people in need of assistance. Over the last year, WHO and its partners provided essential health services, with consultations for more than five million people. More on WHO’s work in Yemen.  Wednesday, 3 March World Hearing Day Hearing loss is the most common sensory disability globally. In view of the prevalence, preventability, and public health impact of this condition, 3 March is observed as World Hearing Day. This year's theme is Hearing care for All! Screen. Rehabilitate. Communicate. More information on the campaign. Launch of the World Report on Hearing Register here for the virtual launch of the first World Report on Hearing taking place on Wednesday from 11:00–12:00 CET. The report highlights the efforts needed to prevent and address hearing loss. When unaddressed, hearing loss poses a significant challenge, hindering language development, communication, cognition, and limiting access to education, employment and social interactions. More on the event page. World Birth Defects Day Most birth defects can be prevented and treated with simple measures. Yet, close to  Thursday, 4 March WHO will launch the Assistive Products Specifications (APS), the first global guide of its kind with specs for 26 priority assistive products that describes the minimum quality requirements for manufacturing. This first compilation of the APS covers mobility, hearing, vision, communication, cognition and self-care. The products range from clubfoot braces and wheelchairs to hearing aids, alarm signalers and audio-players. WHO estimates that out of the one billion people needing at least one assistive product, nine in 10 go without. Barriers to access include the cost and availability of assistive products, the lack of harmonized specifications, broken supply systems. The result for many people in low- and middle-income countries: either no access or only access to low-quality, inappropriate products. More on WHO's work on assistive technology.  Friday, 5 March Guidance on radiotherapy equipment to treat cancer A new publication “Technical specifications of radiotherapy equipment for cancer treatment,” jointly developed by WHO and the International Atomic Energy Agency, provides guidance for the procurement of equipment for radiotherapy, a life-saving cancer treatment option still lacking in many parts of the world. More than 50% of cancer patients will require radiotherapy as part of multi-disciplinary cancer management. Radiation therapy is frequently used to treat the most common types of cancer, such as breast, cervical, colorectal, lung and prostate cancers. The new publication is being released in advance of the launch of WHO’s Global Breast Cancer Initiative, on 8 March. For more information or a copy of the publication in advance, contact mediainquiries@who.int  Receive the latest COVID-19 content, guidance and must-know information from WHO. Sign up for a weekly digital update. Check out the WHO series, Science in 5.  WHO Media contacts:  You are receiving this NO-REPLY email because you are included on a WHO mail list.  |
Friday, February 26, 2021
WHO | Week Ahead for media | 27 February 2021
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment